📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Why Was the Azithromycin "for Life" Trial Necessary? (2024)

First Author: Maitland K

Attributed to: Syndromic infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejme2407000

PubMed Identifier: 39167813

Publication URI: http://europepmc.org/abstract/MED/39167813

Type: Journal Article/Review

Parent Publication: New England Journal of Medicine

Issue: 8

ISSN: 0028-4793